2N
2NH.F Naturhouse Health S.A
- Market cap
- EUR 126M
- P/E
- 14.0x
- P/B
- 8.55x
- ROE
- 56.9%
- Dividend yield
- 14.29%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 2NH.F undervalued?
Graham number2NH.F trades 130.6% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Naturhouse Health S.A fundamental analysis
No fundamental analysis for Naturhouse Health S.A yet.
Naturhouse Health S.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Naturhouse Health S.A
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and food and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising celluli…
Full company profileNaturhouse Health S.A financial statements
Naturhouse Health S.A annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 97.8M | 94.7M | 87.3M | 81.7M | 55.1M | 57.6M | 52.4M | 50.4M | 49.4M | 47.6M |
| Gross Profit | 69.2M | 67.6M | 62.1M | 57.8M | 39.2M | 41.3M | 37.5M | 36.7M | 35.5M | 34.3M |
| Operating Income | 31.6M | 28.2M | 22.1M | 18.7M | 14.4M | 17.5M | 12.8M | 16.3M | 13.1M | 13.2M |
| EBITDA | - | 29.8M | 23.9M | 23.8M | 17.0M | 20.8M | 15.6M | 18.3M | 15.6M | 14.9M |
| Net Income | 22.5M | 19.9M | 15.4M | 13.3M | 9.38M | 13.4M | 9.63M | 11.3M | 9.86M | 10.1M |
| EPS | - | 0.33 | 0.26 | 0.22 | 0.16 | 0.22 | 0.16 | 0.19 | 0.16 | 0.17 |
| Balance Sheet | ||||||||||
| Total Assets | 43.2M | 38.8M | 34.1M | 37.6M | 42.6M | 49.0M | 42.8M | 48.8M | 42.6M | 33.4M |
| Total Liabilities | 16.1M | 14.3M | 15.3M | 21.0M | 16.5M | 12.9M | 15.0M | 18.2M | 10.9M | 15.7M |
| Shareholders' Equity | 27.1M | 24.5M | 18.8M | 16.5M | 26.0M | 36.0M | 27.8M | 30.6M | 31.7M | 17.8M |
| Cash & Short-term Investments | 16.1M | 8.33M | 8.25M | 10.3M | 21.6M | 27.3M | 12.1M | 24.4M | 20.7M | 13.4M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 16.0M | 16.0M | 20.1M | 19.7M | 14.6M | 16.2M | 7.10M | 21.0M | 11.6M | 12.1M |
| Capital Expenditure | 1.16M | 1.20M | 643K | 886K | 201K | 50.0K | 964K | 570K | 338K | 472K |
| Free Cash Flow | - | 14.7M | 19.4M | 18.8M | 14.4M | 16.1M | 6.13M | 20.4M | 11.2M | 11.7M |
| Ratios | ||||||||||
| ROE | 83.0% | 81.1% | 81.6% | 80.6% | 36.1% | 37.1% | 34.6% | 36.9% | 31.1% | 56.9% |
| ROA | 52.0% | 51.1% | 45.1% | 35.3% | 22.0% | 27.3% | 22.5% | 23.1% | 23.2% | 30.2% |
| Net Profit Margin | 23.0% | 21.0% | 17.6% | 16.2% | 17.0% | 23.2% | 18.4% | 22.4% | 20.0% | 21.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Naturhouse Health S.A dividends
- Dividend yield
- 14.29%
- Forward dividend
- 0.20 EUR
- Payout ratio
- 178.3%
- Ex-dividend date
- Nov 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 18.0M | 0.30 | 178.3% |
| 2024 | EUR 12.0M | 0.20 | 121.7% |
| 2023 | EUR 6.00M | 0.10 | 53.1% |
| 2022 | EUR 18.0M | 0.30 | 187.0% |
| 2021 | EUR 3.60M | 0.06 | 26.9% |
| 2020 | EUR 3.60M | 0.06 | 38.4% |
| 2019 | EUR 15.0M | 0.25 | 113.1% |
| 2018 | EUR 20.4M | 0.34 | 132.7% |
| 2017 | EUR 22.8M | 0.38 | 114.8% |
| 2016 | EUR 16.9M | - | 75.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Naturhouse Health S.A
- Insiders 78.26%
- Institutions 1.01%
- Public & others 20.73%
- Shares outstanding 60.0M
- Free float 13.1M
Naturhouse Health S.A company profile
- Company name
- Naturhouse Health S.A
- Ticker
- 2NH.F
- ISIN
- ES0105043006
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 168
- Fiscal year end
- December
- Address
- Calle Claudio Coello 91, Madrid, Spain, 28006
- Phone
- 34 914 32 38 53
- Website
- naturhouse.com
About Naturhouse Health S.A
Naturhouse Health, S.A. operates in the nutrition and dietetics industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and food and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. In addition, the company engages in the production, preparation, and marketing of dietary products; and marketing of medicinal herbs and natural cosmetics. It sells its products through directly operated stores and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. and changed its name to Naturhouse Health, S.A. Naturhouse Health, S.A. was incorporated in 1991 and is based in Madrid, Spain. Naturhouse Health, S.A. is a subsidiary of Kiluva S.A.
Naturhouse Health S.A management
7- Mr. Felix Revuelta FernandezExecutive Chairman & CEO
- Mr. Rafael Bermejo GonzalezFinance & Investment Director
- Mr. Enrique Yeste AlamedaDirector of International Marketing
- Mario Carrasco-Munoz GuerraHead of Internal Audit
- Mr. Frédéric JulienManaging Director of France & Belgium
- Mr. Andrés OrtizHead of Internal Audit
- Mr. Alfonso Baron BastarrecheSecretary of the Board of Directors